세계의 자궁경 검사 기기 시장 - 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

Hysteroscopy instruments market size is set to record a 7.4% CAGR during 2024-2032 driven by the increasing prevalence of gynecological conditions and the rising demand for minimally invasive procedures. Reports indicate that 92% of women globally suffer from one or more gynecological diseases. Hysteroscopy facilitates a detailed examination and treatment of the uterine cavity with minimal surgical intervention. The rising incidence of conditions like abnormal bleeding, polyps, and fibroids, coupled with a shift towards outpatient and minimally invasive procedures, fuels the demand for advanced hysteroscopy instruments.

Furthermore, as medical facilities modernize and access to advanced gynecological care expands, the demand for sophisticated hysteroscopy instruments intensifies. The emergence of technologically advanced tools, such as digital hysteroscopes boasting high-definition imaging and integration capabilities, draws healthcare providers aiming to enhance clinical outcomes and procedural efficiency, adding to the market growth.

The overall industry is divided into type, usability, application, end user, and region.

Based on type, the hysteroscopy instruments market value from the resectoscopes segment is expected to generate notable revenue by 2032 due to their critical role in both diagnostic and therapeutic gynecological procedures. Resectoscopes empower surgeons to precisely resect and remove abnormal tissues, like polyps and fibroids, from the uterine cavity, bolstering the effectiveness of minimally invasive treatments.

Hysteroscopy instruments market size from the diagnostics hysteroscopy application segment is projected to observe a robust CAGR during 2024 - 2032. This is owing to its essential role in the early detection and diagnosis of uterine abnormalities. With the ability to directly visualize the uterine cavity, diagnostic hysteroscopy ensures accurate identification of conditions, such as polyps, fibroids, and endometrial abnormalities. The growing emphasis on early diagnosis and preventative care in gynecology propels the demand for advanced diagnostic tools that promise precise imaging and thorough examination.

Asia Pacific hysteroscopy instruments industry size will grow between 2024 and 2032. The rapid technological advancements in medicine, combined with an emphasis on minimally invasive procedures, are driving the adoption of advanced hysteroscopy instruments. Furthermore, the vast and varied population, increasing healthcare spending, and government efforts to enhance access to superior medical care will further bolster the regional demand for hysteroscopy tools.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing adoption of minimally invasive treatments
    • 3.2.1.2 Increasing adoption of office hysteroscopy
    • 3.2.1.3 Rising incidence of gynecological diseases
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Side effects associated with hysteroscopy procedures
    • 3.2.2.2 Availability of alternative options for diagnosis and treatment of gynecological conditions
• 3.3 Total number of hysteroscopy procedures, 2021 - 2032
• 3.4 Growth potential analysis
• 3.5 Reimbursement scenario
• 3.6 Future market trends
• 3.7 Regulatory landscape
• 3.8 Technological landscape
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hysteroscopes
  • 5.2.1 Rigid hysteroscopes
  • 5.2.2 Flexible hysteroscopes
• 5.3 Resectoscopes
  • 5.3.1 Bipolar resectoscopes
  • 5.3.2 Unipolar resectoscopes
• 5.4 Fluid management systems
• 5.5 Handheld instruments
  • 5.5.1 Forceps
  • 5.5.2 Scissors
  • 5.5.3 Dilators
  • 5.5.4 Other handheld instruments
• 5.6 Hysterosheaths
• 5.7 Hysteroscopic tissue removal systems

Chapter 6 Market Estimates and Forecast, By Usability, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Reusable instruments
• 6.3 Disposable instruments

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Diagnostic hysteroscopy
• 7.3 Operative hysteroscopy
  • 7.3.1 Myomectomy
  • 7.3.2 Polypectomy
  • 7.3.3 Endometrial ablation
  • 7.3.4 Tubal sterilization

Chapter 8 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgery centers
• 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 B. Braun Melsungen AG
• 10.2 Boston Scientific Corporation
• 10.3 CooperSurgical, Inc.
• 10.4 EMOS Technology GmbH
• 10.5 Endoservice GmbH
• 10.6 Erbe Elektromedizin GmbH
• 10.7 Hologic, Inc.
• 10.8 Johnson and Johnson Services, Inc.
• 10.9 KARL STORZ SE and Co. KG
• 10.10 Medtronic plc
• 10.11 Olympus Corporation
• 10.12 Richard Wolf GmbH
• 10.13 Smith and Nephew plc
• 10.14 Stryker Corporation
• 10.15 XION GmbH